Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by General Practitioners each year for checks after experiencing heavy bleeding.
This could potentially reduce the need for more invasive tests such as ultrasounds and biopsies, which can be painful and expensive. The AI test uses machine learning algorithms to analyze blood samples from patients and identify potential signs of womb cancer. However, it's worth noting that the technology is still in its early stages and further research is needed to determine its effectiveness.
The NHS has announced plans to roll out the AI test across several hospitals in England, with initial pilot programs expected to start later this year. The goal is to assess whether the technology can provide accurate results without requiring more invasive tests. While the potential benefits of reducing unnecessary procedures are clear, concerns remain about the potential risks and implications for patients' access to care.